Differential effects of doxorubicin on atrial natriuretic peptide expression in vivo and in vitro

Biological Research

Volumn 34, Issue 3-4, 2001, Pages 195-206

  Rahman, Asim ^c   Alam, Mahmood ^a,b,c   Rao, Sudha ^c   Cai, Lin ^b   Clark, Luther T ^a,c   Shafiq, Sayid ^c   Siddiqui, M A Q ^a,b  

^a SUNY Downstate Medical Center   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Adriamycin; Atrial natriuretic peptide; Gene expression; Heart failure

Indexed keywords

ALPHA ACTIN; ANTINEOPLASTIC AGENT; ATRIAL NATRIURETIC FACTOR; BETA ACTIN; DOXORUBICIN; MESSENGER RNA; PHOSPHOLAMBAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOG; DRUG EFFECT; HEART CELL CULTURE; HEART VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TRANSCRIPTION REGULATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 0035172652     PISSN: 07169760     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-97602001000300007     Document Type: Article

References (28)

1. Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits
2. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro
3. Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects
4. Transcriptional regulation during cardiac growth and development
5. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
6. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
7. Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sacroplasmic reticulum in a chronic rabbit model
8. Ventricular myosin light chain-2 gene expression in developing heart of chicken embryos
9. Comparison of effectiveness of ± - 1,2-Bis(3,5-dioxopiperazinyl-1-yl)propane (IRCF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles
10. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro
11. A novel cardiac-restricted target for doxorubicin
12. cDNA equalization for reverse transcription-polymerase chain reaction quantitation
13. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium
14. Constitutive expression of c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in rhabdomyosarcoma cell line
15. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype
16. Adriamycin cardiotoxicity: A survey of 1273 patients
17. The cellular and molecular response of cardiac myocytes to mechanical stress
18. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane
19. Experimental cardiomyopathy as a model of chronic heart failure
20. Subcellular effects of adriamycin in the heart. A concise review
21. Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin
22. Protective effect of bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer
23. Involvement of phosphorylation in doxorubicin-mediated myofibril degeneration
24. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart
25. Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice
26. Perinatal expression of the atrial natriuretic factor gene in rat cardiac tissue
27. Cross-sectional echocardiography. Analysis of mathematic models for quantifying mass of the left ventricle in dogs